CARGO Therapeutics Statistics

Total Valuation

CRGX has a market cap or net worth of $190.20 million. The enterprise value is -$146.17 million.

Market Cap	190.20M
Enterprise Value	-146.17M

Important Dates

The last earnings date was Wednesday, March 12, 2025, after market close.

Earnings Date	Mar 12, 2025
Ex-Dividend Date	n/a

Share Statistics

CRGX has 46.05 million shares outstanding. The number of shares has increased by 657.22% in one year.

Current Share Class	46.05M
Shares Outstanding	46.05M
Shares Change (YoY)	+657.22%
Shares Change (QoQ)	+0.36%
Owned by Insiders (%)	0.39%
Owned by Institutions (%)	82.79%
Float	27.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.53
P/TBV Ratio	0.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.79, with a Debt / Equity ratio of 0.08.

Current Ratio	13.79
Quick Ratio	13.65
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -43.76% and return on invested capital (ROIC) is -28.44%.

Return on Equity (ROE)	-43.76%
Return on Assets (ROA)	-27.01%
Return on Invested Capital (ROIC)	-28.44%
Return on Capital Employed (ROCE)	-48.16%
Revenue Per Employee	n/a
Profits Per Employee	-$1.00M
Employee Count	167
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.35% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-81.35%
50-Day Moving Average	5.52
200-Day Moving Average	14.55
Relative Strength Index (RSI)	42.53
Average Volume (20 Days)	801,258

Short Selling Information

The latest short interest is 3.55 million, so 7.71% of the outstanding shares have been sold short.

Short Interest	3.55M
Short Previous Month	3.39M
Short % of Shares Out	7.71%
Short % of Float	12.96%
Short Ratio (days to cover)	6.34

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-187.37M
Pretax Income	n/a
Net Income	-167.50M
EBITDA	-184.71M
EBIT	-187.37M
Earnings Per Share (EPS)	-$3.72

Full Income Statement

Balance Sheet

The company has $339.70 million in cash and $29.43 million in debt, giving a net cash position of $338.67 million or $7.35 per share.

Cash & Cash Equivalents	339.70M
Total Debt	29.43M
Net Cash	338.67M
Net Cash Per Share	$7.35
Equity (Book Value)	360.23M
Book Value Per Share	7.82
Working Capital	319.99M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$139.74 million and capital expenditures -$4.45 million, giving a free cash flow of -$144.19 million.

Operating Cash Flow	-139.74M
Capital Expenditures	-4.45M
Free Cash Flow	-144.19M
FCF Per Share	-$3.13

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRGX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-657.22%
Shareholder Yield	n/a
Earnings Yield	-87.01%
FCF Yield	-74.90%

Analyst Forecast

The average price target for CRGX is $4.67, which is 13.08% higher than the current price. The consensus rating is "Hold".

Price Target	$4.67
Price Target Difference	13.08%
Analyst Consensus	Hold
Analyst Count	7
Revenue Growth Forecast (5Y)	16.98%
EPS Growth Forecast (5Y)	-15.16%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1